Using 3D technology for personalized nasal reconstruction
Regenerative Medicine Approach to Nasal Reconstruction
This study is testing if using 3D technology for personalized nasal reconstruction can make surgery safer and more effective for people with nasal defects from cancer, trauma, or previous surgeries.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Trial ID | NCT05273060 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the safety and effectiveness of a regenerative medicine approach to nasal reconstruction by comparing traditional surgical planning methods with advanced 3D preoperative scanning, printing, and planning techniques. Patients with nasal defects due to cancer, trauma, or prior surgeries will be involved, and the study will focus on creating individualized cartilage grafts and skin templates using 3D technology. The goal is to improve surgical outcomes, reduce operative times, and enhance the overall patient experience by providing tailored solutions for nasal reconstruction.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 100 who require nasal reconstruction due to various defects.
Not a fit: Patients under 18 years old will not benefit from this study as their cases are managed differently.
Why it matters
Potential benefit: If successful, this approach could lead to more effective and personalized nasal reconstruction procedures for patients.
How similar studies have performed: Other studies have shown promise in using 3D technology for surgical planning, indicating potential success for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males or female, age range is ≥ 18 to ≤ 100, based on historical surgical experience. * Patients undergoing nasal reconstruction. * Patients will be identified from the Facial Plastic Surgery clinic of the PI. Exclusion Criteria: - Patients \< 18 are excluded because these cases are in combination with providers from PCH and patients have shared/limited postoperative follow up as a result.
Where this trial is running
Phoenix, Arizona
- Mayo Clinic Arizona — Phoenix, Arizona, United States (Recruiting)
Study contacts
- Principal investigator: Brittany Howard, MD — Mayo Clinic
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.